|
Match
|
Document |
Document Title |
|
|
7214385 |
Pharmaceutical formulation containing dye
Methods and compositions for preventing abuse of dosage forms comprising an opioid analgesic and an aversive agent (e.g., a dye) in an effective amount to deter an abuser from administering a...
|
|
|
7208175 |
Process for the production of rapidly disintegrating, solid pharmaceutical preparations
Rapidly disintegrating preparations containing at least one active pharmaceutical ingredient and at least one excipient can be obtained by a simple process in which at least the predominant part of...
|
|
|
7186293 |
Agglomerated starch compositions
Agglomerated starch compositions containing native starch and pre-compacted starch powder is disclosed. The agglomerated starch compositions have superior flow and less pH sensitivity than simple...
|
|
|
7182959 |
Rapidly dissolving dosage form and process for making same
The invention relates to a solid dosage form which is rapidly disintegrating in aqueous medium. Especially, the invention relates to pharmaceutical, orally ingested solid dosage forms, which are...
|
|
|
RE39497 |
Storage of materials
A material or mixture of materials which is not itself storage stable is rendered storage stable by incorporation into a water-soluble or swellable glassy or rubbery composition which can then be...
|
|
|
7179486 |
Process for preparing sustained release tablets
The present invention is directed to the process of preparing a sustained release niacin tablet and the product prepared therefrom.
|
|
|
7175854 |
Pharmaceutical preparation comprising an active dispersed on a matrix
The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a...
|
|
|
7163699 |
Progestin co-micronized with a surfactant pharmaceutical composition comprising same methods for making same and uses thereof
The invention concerns a progestin co-micronized with a surfactant and a pharmaceutical composition comprising said gestagenic. The invention also concerns methods for preparing same.
|
|
|
7157100 |
Pharmaceutical composition for controlled drug delivery system
The present invention describes a novel controlled release multilayer composition that is capable of delivering a first active agent from one layer immediately followed by continuous controlled...
|
|
|
7144585 |
Cilostazol preparation
Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility....
|
|
|
7141593 |
Pharmaceutical formulations
Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds having improved solubility properties in a medium and/or long chain fatty...
|
|
|
7141249 |
Rapidly soluble drug composition
A fast-dissolving pharmaceutical composition comprising micronized (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2
-a]pyrazine-4-spiro-3′-pyrrolidine-1,2′,3,5′-tetrone...
|
|
|
7138138 |
Pharmaceutical formulation having a masked taste and method for the production thereof
The invention relates to a pharmaceutical formulation in the form of a powder which is administered orally in an aqueous suspension, having a masked taste, and comprising at least one cellulose...
|
|
|
7138137 |
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by...
|
|
|
7132114 |
Rapidly disintegrating methylcellulose tablets
The present invention relates to a novel pharmaceutical composition and process for preparing swallowable methylcellulose tablets that disintegrate rapidly and meet USP disintegration standards in...
|
|
|
7125562 |
Rapidly disintegrating methylcellulose tablets
The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has a first phase and a second phase blended with the first phase. The first phase has a...
|
|
|
7125567 |
Process for producing an oral sustained-release preparation of fasudil hydrochloride
Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
|
|
|
7122198 |
Fast dissolving composition with prolonged sweet taste
A novel fast dissolving pharmaceutical composition in solid dosage form with prolonged sweet taste which comprises (a) At least one pharmaceutically active agent, (b) At least one water soluble...
|
|
|
7122204 |
Antibiotic composition with inhibitor
Antibiotic composition having four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor, followed...
|
|
|
7118765 |
Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
The present invention comprises a co-processed carbohydrate system, and formulations produced therefrom, which formulations are directly compressible into solid dosage forms, some of which rapidly...
|
|
|
7118762 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
7115281 |
Processes for the preparation of oral dosage formulations of modafinil
The invention relates to processes for preparing, and pharmaceutical compositions of, modafinil dosage forms for oral administration. The dosage forms include a mixture of coarse and fine particles...
|
|
|
7108864 |
Tablet formation
Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the...
|
|
|
7108866 |
Chronotherapeutic diltiazem formulations and the administration thereof
A controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for evening dosing every 24 hours containing...
|
|
|
7105179 |
Crystal forms of azithromycin
The invention relates to novel crystal forms of azithromycin, an antibiotic useful in the treatment of infections.
|
|
|
7101569 |
Methods of administering levothyroxine pharmaceutical compositions
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized...
|
|
|
7101573 |
Simethicone solid oral dosage form
The present invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent,...
|
|
|
7097851 |
Oral formulation for gastrointestinal drug delivery
An oral formulation for gastrointestinal drug delivery which comprises an adhesion site-controlling layer for attaching the formulation to the selected site in the digestive tract, a drug-carrying...
|
|
|
7094427 |
Combination immediate release controlled release levodopa/carbidopa dosage forms
The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated...
|
|
|
7083807 |
Pharmaceutical compositions for the controlled release of active substances
The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising
a) the said at least one active...
|
|
|
7083808 |
Controlled/modified release oral methylphenidate formulations
The invention is directed to oral modified/controlled release methylphenidate formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak...
|
|
|
7074429 |
Fosinopril sodium tablet formulation
Stable tablets comprising fosinopril sodium are prepared by employing either stearic acid or zinc stearate as the lubricant.
|
|
|
7074428 |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
The present invention pertains to a quick disintegrating tablet in buccal cavity, characterized in that drug-containing particles with a mean particle diameter of approximately 50 to approximately...
|
|
|
7070804 |
Chewable tablet containing lysine
A tablet with enhanced compliance by humans, in particular children and/or juveniles, comprising:
(a) a vitamin; (b) lysine or a pharmaceutically acceptable salt thereof; (c) a sweetener;...
|
|
|
7070817 |
Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
The invention relates to an herbal composition comprising extract of plant Moringa Oleifera , a member of family Moringaceae, plant Piper Nigrum , a member of family Piperaceae and plant ...
|
|
|
7070811 |
Directly compressible formulations of azithromycin
The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable...
|
|
|
7067149 |
Fast disintegrating tablet
The invention concerns an improved multiparticulate tablet disintegrating in the mouth in contact with saliva in less than 40 seconds. The invention is characterized in that it is based on...
|
|
|
RE39149 |
Method of administering azithromycin
An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets;...
|
|
|
7067148 |
Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
A pharmaceutical composition with β-sheet microcrystalline cellulose with improved potency life and methods of preparation therefor. Improved thyroid hormone pharmaceutical compositions comprising...
|
|
|
7063862 |
Pharmaceutical composition and method for treating
Embodiments of the invention generally provide pharmaceutical drug compositions, methods of preparing oral drug compositions, such as extended release dosage compositions, and methods for treating...
|
|
|
7060294 |
Compressed tablet formulation
This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the...
|
|
|
7056531 |
Sustained release compositions for orally administered substances and methods
Sustained release composition for orally administered active substances that comprises maltodextrin and cellulose. This composition is suitable for forming tablets, gels when exposed to the fluids...
|
|
|
7052717 |
Storage stable thyroxine active drug formulations and methods for their production
This invention provides a storage-stable dosage form of a thyroxine active drug composition which exhibits an improved stability. The formulation contains a thyroxine active drug substance and an...
|
|
|
7041319 |
Fenofibrate pharmaceutical composition having high bioavailabilty
The invention provides fenofibrate tablets comprising granulates, wherein the granulates can comprise carrier particles, micronized fenofibrate, and at least one hydrophilic polymer.
|
|
|
7037529 |
Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
The invention provides an immediate-release fenofibrate composition comprising (a) an inert hydrosoluble carrier covered with at least one layer containing fenofibrate in a micronized form having a...
|
|
|
7037525 |
Oxacarbazepine film-coated tablets
The invention relates to formulations, e.g. film-coated tablets containing oxcarbazepine and to processes for the production of said formulations. The film-coated tablets have a tablet core...
|
|
|
7033612 |
Composition and method for treating age-related disorders
There is provided a composition for the prevention and treatment of age-related physical and mental disorders that includes phospholipids that have been extracted from chick embryos aged between...
|
|
|
7029699 |
Soft chewable tablets
The present invention relates to a compressed, chewable tablet containing at least one active ingredient, a water-disintegratable, compressible carbohydrate and a binder. These components are dry...
|
|
|
7030106 |
Sterol absorption inhibitor compositions
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one peroxisome proliferator-activated receptor activator; and (b) at least one substituted...
|
|
|
7022338 |
Tablets comprising micro-organisms and method for preparation of the tablets
Tablet containing living micro-organisms, produced from a pressed tablet material comprising micro-organisms and oligosaccharides and/or polysaccharides, the tablet material also comprising at...
|